MARKER THERAPEUTICS INC (MRKR) Stock Analyst Ratings

NASDAQ:MRKR • US57055L2060

1.43 USD
-0.01 (-0.69%)
At close: Feb 13, 2026
1.5 USD
+0.07 (+4.9%)
After Hours: 2/13/2026, 8:26:57 PM
Buy % Consensus

82

ChartMill assigns a Buy % Consensus number of 82% to MRKR. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 9.21. This target is 543.74% above the current price.
  • MRKR was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about MRKR.
  • In the previous month the buy percentage consensus was at a similar level.
  • MRKR was analyzed by 9 analysts. More opinions would make the average more meaningful.
MRKR Historical Analyst RatingsMRKR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 1.435.669.189.2113.13 - 295.52% 541.96% 543.74% 817.83%
MRKR Current Analyst RatingMRKR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5
Up and Down Grades
Date Firm Action Rating
2025-12-08 HC Wainwright & Co. Initiate Buy
2025-04-01 WBB Securities Reiterate Strong Buy -> Strong Buy
2025-03-05 Canaccord Genuity Initiate Buy
2024-10-21 Ladenburg Thalmann Maintains Buy -> Buy
2024-04-30 Ladenburg Thalmann Initiate Buy
2022-02-17 Roth Capital Downgrade Buy -> Neutral
2021-03-25 Piper Sandler Initiate Overweight
2021-03-19 Cantor Fitzgerald Initiate Overweight
2021-03-18 Cantor Fitzgerald Initiate Overweight

MARKER THERAPEUTICS INC / MRKR FAQ

What is the price target for MRKR stock?

9 analysts have analysed MRKR and the average price target is 9.21 USD. This implies a price increase of 543.74% is expected in the next year compared to the current price of 1.43.


How do analysts rate MARKER THERAPEUTICS INC (MRKR)?

The consensus rating for MARKER THERAPEUTICS INC (MRKR) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.